| Authors: |
Alkhabbaz O; Texas College of Osteopathic Medicine, University of North Texas Health Science Center, Fort Worth, USA., Mohamed A; Internal Medicine, University of Texas Southwestern Medical Center, Dallas, USA., Alshaikhsalama A; Ophthalmology, University of Texas Southwestern Medical Center, Dallas, USA., Kanjwal S; Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, USA., Alkhani A; Internal Medicine, Northside Hospital Gwinnett, Lawrenceville, USA., Atassi B; Hematology and Oncology, Little Company of Mary Medical Center, Evergreen Park, USA., Ahmad Z; Endocrinology, University of Texas Southwestern Medical Center, Dallas, USA., Alomar A; Interventional Cardiology, Methodist Health System, Dallas, USA., Hallab A; Nephrology, Indiana University Health Bloomington Hospital, Bloomington, USA., Ghalib L; Endocrinology and Diabetes, The Ohio State University Wexner Medical Center, Columbus, USA., Alahmadi A; Medical Oncology, The Ohio State University Wexner Medical Center, Columbus, USA., Droubi R; Healthcare Administration, University of Houston - Clear Lake, Houston, USA., Mourad H; Pharmacology, Mayo Clinic, Rochester, USA., Rashdan S; Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, USA. |
